Saturday, October 31, 2026

Boston Properties Stock Falls By 15% In The Last 5 Sessions

Boston Properties Stock Falls By 15% In The Last 5 Sessions

(VIANEWS) - Shares of Boston Properties (NYSE: BXP) slid by a staggering 15.54% in 5 sessions from $66.15 to $55.87 at 13:26 EST on Monday, after two sequential sessions in a row of losses. NYSE is sliding 0.55% to $14,812.29, after two consecutive sessions in a row of losses.

Boston Properties's last close was $57.44, 56.85% below its 52-week high of $133.11.

About Boston Properties

Boston Properties (NYSE:BXP) is the largest publicly-held developer and owner of Class A office properties in the United States, concentrated in five markets - Boston, Los Angeles, New York, San Francisco and Washington, DC. The Company is a fully integrated real estate company, organized as a real estate investment trust (REIT), that develops, manages, operates, acquires and owns a diverse portfolio of primarily Class A office space. The Company's portfolio totals 51.2 million square feet and 196 properties, including six properties under construction/redevelopment.

Earnings Per Share

As for profitability, Boston Properties has a trailing twelve months EPS of $2.93.

PE Ratio

Boston Properties has a trailing twelve months price to earnings ratio of 19.09. Meaning, the purchaser of the share is investing $19.09 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.45%.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is a negative 44% and a negative 57.7%, respectively.

Moving Average

Boston Properties's value is way below its 50-day moving average of $69.29 and way below its 200-day moving average of $78.63.

Volume

Today's last reported volume for Boston Properties is 1891466 which is 34.3% above its average volume of 1376220.

Yearly Top and Bottom Value

Boston Properties's stock is valued at $55.87 at 13:26 EST, under its 52-week low of $57.35.

More news about Boston Properties (BXP).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com